By Matthew Bultman ( March 17, 2015, 3:12 PM EDT) -- The Federal Circuit agreed Tuesday to hear arguments over a judge's decision that Mylan Pharmaceuticals Inc. is subject to jurisdiction in Delaware in a suit over generic versions of AstraZeneca AB drugs, a case Mylan contends could provide guidance to lower courts in a Hatch-Waxman law....
Law360 is on it, so you are, too.
A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.
A Law360 subscription includes features such as
- Daily newsletters
- Expert analysis
- Mobile app
- Advanced search
- Judge information
- Real-time alerts
- 450K+ searchable archived articles
And more!
Experience Law360 today with a free 7-day trial.